Loading...
 Business Korea.jpg)
08-Jan-15 Korea’s domestic pharmaceutical R&D industry progressed strongly in 2014, securing approval of its 21st domestically developed drug, Liavax, and the entry of new medicines such as Kanarb and Supect onto the global market. In 2015 new Korean drugs for chemo-induced neutropenia, obesity and arthritis are expected to hit the market, as well as several new vaccines. [image: Business Korea]
Read MoreAccess to medicine index.jpg)
01-Dec-14 The top 20 pharmaceutical companies are developing 327 products for developing countries - yet only five of them account for more than half of these: Novartis, Johnson & Johnson, GSK, AbbVie and Sanofi. [image: Access to medicine index]
Read More Business Korea.png)
21-Mar-14 Korea has announced plans to become one of the top seven countries in the global medical device sector by 2020. This is reminiscent of the country's plan about 15 years ago to become one of the top three in mobile phones within ten years. It happened! Expect to see a lot more from Korean med tech firms in international markets.
Read More